期刊文献+

^(188)Re标记免疫靶向磁性纳米微粒及其生物学分布 被引量:5

^(188)Re labeling and biodistribution of magnetic nanoparticles for the tumor targeting
下载PDF
导出
摘要 目的研究 ^(188)Re 标记具有 HER-2/neu 癌基因靶向特异性的 Herceptin 免疫磁性纳米微粒及其在小鼠体内的生物学分布,方法利用戊二醛作为交联剂,将人源性单克隆抗体 Herceptin 与化学修饰的磁性纳米微粒进行连接,构建免疫磁性纳米微粒。采用直接标记法将 ^(188)Re 标记到免疫磁性纳米微粒上。采用羰基铼标记法,以 fac-[^(188)Re(CO)_3(H_2O)_3]^+作为放射性标记前体,对表面固载组氨酸的磁性纳米微粒进行标记。分别测定所制备 ^(188)Re 标记物的标记率和体外稳定性及免疫磁性纳米微粒的单克隆抗体免疫活性,并观察 ^(188)Re 标记的磁性纳米微粒及免疫磁性纳米微粒的小鼠体内生物分布。结果经扫描电镜证实免疫磁性纳米微粒的单个粒径大小平均为60 nm,而表面固载组氨酸的磁性纳米微粒的粒径平均为30 nm。^(188)Re 对 Herceptin、免疫磁性纳米做粒及固载组氨酸的磁性纳米微粒的标记率均>90%,在小牛血清中具有良好的体外稳定性,并且磁性纳米微粒上连接的单克隆抗体仍保持较高的免疫活性。小鼠体内分布实验显示 ^(188)Re 标记的磁性纳米微粒及免疫磁性纳米微粒在血液中有较高的放射性分布且血循环时间较长,同时两者在肝内均有较多的摄取。结论 ^(188)Re 标记的磁性纳米微粒及免疫磁性纳米微粒在体外及动物体内较稳定,无明显的 ^(188)Re 脱落。可用于下一步荷瘤裸鼠体内的研究。 Objective To prepare ^188Re labeled monoclonal antibody (Herceptin)-coated magnetic nanoparticles for tumor targeting and to study its biodistribution in mice. Methods Herceptin and histidine were covalently linked to the amine group upon silica-coated magnetic nanoparticles modified by N-[3-( trimethyoxysilyl) propyl ]-ethylenediamine using glutaraldehyde method. The Heceptin-coated magnetic nanoparticles and Herceptin were radiolabeled with ^188Re by a direct labelling method, whereas the histidine-coated magnetic nanoparticles was radiolabeled with ^188Re using fac-[^188Re(CO)3(H2O)3 ]^+ as a precursor. The labelling efficiency and immunoreactivity as well as labelling stability were determined. Also, the biodistribution of ^188Re-magnetic and ^188Re-Herceptin-magnetic nanoparticles were observed in mice. Results Herceptin-coated magnetic nanoparticles was characterized by transmission electron microscope (TEM) with diameter about 60 nm, while histidine-coated magnetic nanoparticles about 30 nm. The labeling efficiency for ^188Re-Herceptin, ^188Re-magnetic nanoparticles and ^188Re-Herceptin-magnetic nanoparticles were all 〉 90% and had a better stability in vitro. The immunoreactivity of Herceptin linked to magnetic nanoparticles was still high. The biodistribution in mice was shown that ^188Re-magnetic nanoparticles and ^188Re-Herceptin-magnetic nanoparticles had higher radioactivity levels in blood. Magnetic nanoparticles with diameter of 30 or 60 nm had a long half-life in blood stream and were accumulated in liver. Conclusion The efficiency and stability of labelling Herceptin-coated magnetic nanoparticles and labeling magnetic nanoparticles with raRe are suitable for in vivo study in tumor-bearlng nude mice models.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2006年第4期231-235,共5页 Chinese Journal of Nuclear Medicine
基金 中国博士后科学基金(2003033345)
关键词 磁性纳米微粒 同位素标记 药代动力学 小鼠 Magnetic nanoparticles Isotope labeling Rhenium Pharmacokinetics Mice
  • 相关文献

参考文献11

  • 1Pankhurst QA, Connolly J, Jones SK, et al. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys, 2003, 26 : R167-R181. 被引量:1
  • 2Tartaj P, Morales MP, Veintemillas-Verdaguer S, et al. The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys, 2003, 26 : R182-R197. 被引量:1
  • 3Berry CC, Curtis ASG. Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys, 2003, 26:R198-R206. 被引量:1
  • 4Zhang CF, Cao JQ, Yin DZ, et al. Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot, 2004, 61 : 1255-1259. 被引量:1
  • 5曹金全,汪勇先,于俊峰,李世强,夏姣云,张春富,尹端氵止.磁性纳米微粒的^(188)Re标记[J].同位素,2004,17(2):84-89. 被引量:6
  • 6苗积生,沈毅.核素标记抗体与抗原亲和常数及结合容量测定[J].中华核医学杂志,2001,21(5):311-313. 被引量:3
  • 7Jennifer LW, Naomi JH. Application of nanotechnology to biotechnology: commentary. Curr Opin Biotech, 2000, 11 : 215-217. 被引量:1
  • 8Sorsa MH, Rubim JH, Sobrinho PG, et al. Biocompatible magnetic fluid precursors based on aspartic and glutamic acid modified maghemite nanostructures. J Magn Magn Mater, 2001, 225: 67-72. 被引量:1
  • 9Funovics MA, Kapeller B, Hoeller C, et al. MR imaging of the HER2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging, 2004, 22: 843-850. 被引量:1
  • 10范莉,王东琪,吴永慧,王祥云,刘元方,杨志,张梅颖.^(188)Re直接法标记抗人结肠癌单克隆抗体CL-3的研究[J].同位素,2000,13(2):83-87. 被引量:2

二级参考文献32

  • 1苗积生,沈毅,吴吉勇.放射性核素标记单克隆抗体(McAb)免疫反应活性分数的测定[J].同位素,1996,9(2):85-88. 被引量:7
  • 2Widder KJ,Senyei AE,Scarpelli DG.Magnetic Microspheres:a Model System for Site Specific Drug Delivery in Vivo[J].Proc Soc Exp Bio Med,1978,58:141-146. 被引量:1
  • 3Hafeli UO,Pauer GJ,Macklis RM.Treatment of Mouse Tumors With Radioactive Magnetic Microspheres:Model for Intracavitary Radiotherapy[J].Proceedings of the International Symposium on Controlled Release of Bioactive Materials,1995,22:89~90. 被引量:1
  • 4Hafeli UO,Sweeney SM,Beresford BA,et al.Effective Targeting of Magnetic Radioactive 90Y-microspheres to Tumor Cells by an Externally Applied Magnetic Field.Preliminary in Vitro and in Vivo Results[J].Nucl Med Biol,1995,22(2):147~155. 被引量:1
  • 5Hafeli UO,Pauer GJ,Roberts WK,et al.Magnetically Targeted Microspheres for Intracavitary and Intraspinal Y-90 Radiotherapy[A].International Conf on Scientific and Clinical Applications of Magnetic Carriers[C].New York:Plenum Press.1997. 被引量:1
  • 6Hafeli UO,Pauer GJ,Failing S,et al.Radiolabeling of Magnetic Particles With Rhenium-188 for Cancer Therapy[J].J Magn Magn Mat,2001,225:73-78. 被引量:1
  • 7Hafeli UO.Radiolabeled and Magnetic Particulates in Medicine and Biology[R],MML Series Vol3.London:Citus Books,2001.18. 被引量:1
  • 8Junfeng Y,Hafeli UO,Dong Y,et al.Radiolabeling of Magnetic Targeted Carriers With Several Therapeutic and Imaging Radioisotopes[J].Euro Cells Mat,2002,3 (2Suppl):16-18. 被引量:1
  • 9Shinkai M.Functional Magnetic Particles forMedical Application [J].J Biosci Bioeng,2002,94(6):606-613. 被引量:1
  • 10Xu Z,Gu Y.Magnetic Nanoparticles for Biose-peration Application and Methods for Producing Same[P].Canada:WO 03/005029 A2,2003-01-16. 被引量:1

共引文献6

同被引文献70

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部